论文信息 - Phase I and Pharmacokinetic (PK) Study of Everolimus (RAD001) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL). - 字舞流文

Phase I and Pharmacokinetic (PK) Study of Everolimus (RAD001) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL).

M. Taniwaki | M. Ogura | K. Tobinai | D. Maruyama | T. Uchida | N. Uike | K. Ishizawa | K. Itoh | K. Ando | N. Shimada | Ken Kobayashi | I. Choi